Quantcast Anaptysbio Inc Stock Quote | Stock Price for ANAB | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Anaptysbio Inc (NQ: ANAB)
68.58 USD  +4.09 (+6.34%)
Official Closing Price  /  Updated: 5:24 PM EST, Nov 16, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 400,500
Open 63.59
Bid (Size) 66.39 (2)
Ask (Size) 106.80 (1)
Prev. Close 64.49
Today's Range 63.59 - 68.68
52wk Range 62.56 - 134.00
Shares Outstanding 23,497,680
Dividend Yield N/A
Performance
YTD
-31.82%
-31.82%
1 Month
-15.71%
-15.71%
3 Month
-20.37%
-20.37%
6 Month
-21.69%
-21.69%
1 Year
-8.39%
-8.39%
Top News
More News
AnaptysBio Announces Third Quarter 2018 Financial Results and Provides Pipeline Updates
AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today reported operating... Read More
from GlobeNewswire News Releases
AnaptysBio to Participate in Upcoming Investor Conferences
AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza... Read More
from GlobeNewswire News Releases
More News
Read More
Research Report Identifies AnaptysBio, Imperial Oil, Norbord, 3D, Apple Hospitality REIT, and Pinnacle Foods with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
from GlobeNewswire News Releases
AnaptysBio Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option
from GlobeNewswire News Releases
AnaptysBio Announces Pricing of Public Offering of Common Stock
from GlobeNewswire News Releases
AnaptysBio Announces Proposed Public Offering of Common Stock
from GlobeNewswire News Releases
Implied JKJ Analyst Target Price: $196
category ETFs
from ETF Channel
Why This Rival Won't Threaten Regeneron's Potential Blockbuster
from Investor's Business Daily
Here's Why AnaptysBio, Inc. Slipped on Friday
category TSRO , Market News , ANAB
from Motley Fool
AnaptysBio Inc. Sets Up More Shots on Goal in the Third Quarter
category TSRO , ANAB , Market News
from Motley Fool
Sum Up The Pieces: FAD Could Be Worth $81
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.